Colgate-Palmolive Co (CL) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 2, 2026.

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free
Filings shown
27
Open-market buys
0
Open-market sells
5

Counts cover the 27 most recent Form 4 filings Tradune holds for CL (filed May 18 – Oct 2, 2026); the score below covers only the trailing 90 days (0 buys, 4 sells). No completed check of CL's Form 4 list on SEC EDGAR is on record yet; the latest CL filing Tradune holds was filed Oct 2, 2026. This is not guaranteed to be the complete record — see CL's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 22 filings Tradune holds for CL filed Aug 6 – Oct 2, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

4 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
0 sales· 0 sh
checkbox disclosed
On filings with the box not checked
4 sales· 336,212 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Noel R. WallaceChairman, President & CEO 0 2 — 322,042 −$29,698,617
Panagiotis TsourapasCOO, CD, EMEA, APac, Skin 0 1 — 10,000 −$920,477
John T. CahillDirector 0 1 — 4,170 −$389,358

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score
0/ 100
Net insider sales
0 distinct buyers0 buy · 4 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at CL

No open-market insider purchases (Form 4 code P) were reported for CL between May 18, 2026 and Oct 2, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Lorrie M. Norrington Director · filed Oct 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 300 $87.42 43,310 +0.7% Oct 1, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

Brian Newman Director · filed Oct 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 214 $87.42 8,058 +2.7% Oct 1, 2026
John P. Bilbrey Director · filed Oct 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 271 $87.42 40,725 +0.7% Oct 1, 2026
Noel R. Wallace Chairman, President & CEO · filed Sep 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 29,649 — 379,700 +8.5% Sep 16, 2026
Grant / award Stock Option (Right to Buy) 205,197 — — — Sep 16, 2026
Shane Grant COO, Americas · filed Sep 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 7,355 — 79,503 +10% Sep 16, 2026
Grant / award Stock Option (Right to Buy) 50,902 — — — Sep 16, 2026
Panagiotis Tsourapas COO, CD, EMEA, APac, Skin · filed Sep 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 31,814 — — — Sep 16, 2026
Grant / award 4,597 — 11,447 +67% Sep 16, 2026
Stanley J. Sutula III Chief Financial Officer · filed Sep 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 55,674 — — — Sep 16, 2026
Grant / award 8,045 — 79,029 +11% Sep 16, 2026
John Hazlin Chief Growth Officer · filed Sep 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 27,042 — — — Sep 16, 2026
Grant / award 3,908 — 27,021 +17% Sep 16, 2026
Sally Massey Chief People Officer · filed Sep 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 23,065 — — — Sep 16, 2026
Grant / award 3,333 — 15,397 +28% Sep 16, 2026
Betsy Fishbone CLO and Secretary · filed Sep 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 15,271 — — — Sep 16, 2026
Grant / award 2,207 — 16,050 +16% Sep 16, 2026
Gregory Malcolm EVP and Controller · filed Sep 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 7,477 — — — Sep 16, 2026
Grant / award 1,081 — 14,162 +8.3% Sep 16, 2026
Noel R. Wallace Chairman, President & CEO · filed Sep 15, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 4,892 $86.80 350,051 −1.4% Sep 13, 2026
Tax withholding 3,516 $86.80 354,943 −1.0% Sep 12, 2026
Tax withholding 4,071 $86.80 358,459 −1.1% Sep 11, 2026
Panagiotis Tsourapas COO, CD, EMEA, APac, Skin · filed Sep 15, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 922 $86.80 6,850 −12% Sep 13, 2026
Tax withholding 618 $86.80 7,772 −7.4% Sep 12, 2026
Tax withholding 684 $86.80 8,390 −7.5% Sep 11, 2026
Stanley J. Sutula III Chief Financial Officer · filed Sep 15, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 1,385 $86.80 70,984 −1.9% Sep 13, 2026
Tax withholding 927 $86.80 72,369 −1.3% Sep 12, 2026
Tax withholding 1,197 $86.80 73,296 −1.6% Sep 11, 2026
Sally Massey Chief People Officer · filed Sep 15, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 686 $86.80 12,064 −5.4% Sep 13, 2026
Tax withholding 459 $86.80 12,750 −3.5% Sep 12, 2026
Tax withholding 651 $86.80 13,209 −4.7% Sep 11, 2026
Gregory Malcolm EVP and Controller · filed Sep 15, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 225 $86.80 13,081 −1.7% Sep 13, 2026
Tax withholding 151 $86.80 13,306 −1.1% Sep 12, 2026
Tax withholding 167 $86.80 13,457 −1.2% Sep 11, 2026
John Hazlin Chief Growth Officer · filed Sep 15, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 499 $86.80 23,113 −2.1% Sep 13, 2026
Tax withholding 439 $86.80 23,612 −1.8% Sep 12, 2026
Tax withholding 649 $86.80 24,051 −2.6% Sep 11, 2026
Betsy Fishbone CLO and Secretary · filed Sep 15, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 472 $86.80 13,843 −3.3% Sep 13, 2026
Tax withholding 331 $86.80 14,315 −2.3% Sep 12, 2026
Tax withholding 404 $86.80 14,646 −2.7% Sep 11, 2026
Shane Grant COO, Americas · filed Sep 15, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 622 $86.80 72,148 −0.9% Sep 11, 2026
Panagiotis Tsourapas COO, CD, EMEA, APac, Skin · filed Aug 26, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 10,000 $92.05 64,901 (indirect) −13% Aug 24, 2026

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

John T. Cahill Director · filed Aug 7, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 4,170 $93.37 28,373 −13% Aug 6, 2026
Option exercise Stock Option (Right to Buy) 4,170 — — — Aug 6, 2026
Option exercise 4,170 $71.56 32,543 +15% Aug 6, 2026
Noel R. Wallace Chairman, President & CEO · filed Aug 6, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Stock Option (Right to Buy) 161,021 — — — Aug 5, 2026
Open-market sale 10b5-1 box not checked 161,021 $92.52 362,231 −31% Aug 5, 2026
Option exercise 161,021 $72.29 523,252 +44% Aug 5, 2026
Option exercise 161,021 $72.29 523,252 +44% Aug 4, 2026
Open-market sale 10b5-1 box not checked 161,021 $91.92 362,231 −31% Aug 4, 2026
Option exercise Stock Option (Right to Buy) 161,021 — — — Aug 4, 2026
Lorrie M. Norrington Director · filed Jul 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 293 $89.45 42,769 +0.7% Jul 1, 2026
Brian Newman Director · filed Jul 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 209 $89.45 7,831 +2.7% Jul 1, 2026
John P. Bilbrey Director · filed Jul 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 265 $89.45 40,229 +0.7% Jul 1, 2026

Listing the 25 most recent of 27 Form 4 filings held for CL; the 2 older filings (filed May 18 – Jun 17, 2026) are counted above but not listed here — see CL's full Form 4 filing history on SEC EDGAR.

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to CL's (Oct 2, 2026).

Frequently asked about CL insider activity

How many insiders bought CL stock in these Form 4 filings?

No open-market purchases (Form 4 code P) of CL shares were reported by Colgate-Palmolive Co insiders between May 18, 2026 and Oct 2, 2026. The 27 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.

Who filed the most recent Form 4 for CL?

The most recent Form 4 on this page was filed by John P. Bilbrey (Director) on Oct 2, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market CL insider sale shown?

The largest open-market sale among the filings shown was 161,021 CL shares at $92.52 (about $14,897,904) by Noel R. Wallace (Chairman, President & CEO) on Aug 5, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for CL — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

Track CL insider filings free →

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.